Neurofilament Light Chain Levels Are Predictive of Clinical Conversion in Radiologically Isolated Syndrome
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received March 8, 2022
- Accepted in final form August 29, 2022
- First Published October 24, 2022.
Author Disclosures
- Manon Rival, MD*,
- Eric Thouvenot, MD, PhD*,
- Lucile Du Trieu de Terdonck, PhD,
- Sabine Laurent-Chabalier, PhD,
- Christophe Demattei, PhD,
- Ugur Uygunoglu, MD,
- Giovanni Castelnovo, MD,
- Mikael Cohen, MD, PhD,
- Darin T. Okuda, MD, PhD,
- Orhun H. Kantarci, MD, PhD,
- Daniel Pelletier, MD,
- Christina Azevedo, MD, PhD,
- Philippe Marin, PhD,
- Sylvain Lehmann, MD, PhD,
- Aksel Siva, MD, PhD,
- Thibault Mura, MD, PhD and
- Christine Lebrun-Frenay, MD, PhD
- on behalf of SFSEP and RISC
- Manon Rival, MD*,
None
NONE
None
NONE
NONE
NONE
NONE
I have served as a consultant for EMD Serono, Genentech and Novartis
NONE
NONE
NONE
NONE
NONE
NONE
National MS Society grant funding to support neuroimmunology fellowship
NONE
NONE
NONE
NONE
NONE
NONE
- Eric Thouvenot, MD, PhD*,
None
NONE
None
NONE
NONE
NONE
NONE
I have served as a consultant for EMD Serono, Genentech and Novartis
NONE
NONE
NONE
NONE
NONE
NONE
National MS Society grant funding to support neuroimmunology fellowship
NONE
NONE
NONE
NONE
NONE
NONE
- Lucile Du Trieu de Terdonck, PhD,
None
NONE
None
NONE
NONE
NONE
NONE
I have served as a consultant for EMD Serono, Genentech and Novartis
NONE
NONE
NONE
NONE
NONE
NONE
National MS Society grant funding to support neuroimmunology fellowship
NONE
NONE
NONE
NONE
NONE
NONE
- Sabine Laurent-Chabalier, PhD,
None
NONE
None
NONE
NONE
NONE
NONE
I have served as a consultant for EMD Serono, Genentech and Novartis
NONE
NONE
NONE
NONE
NONE
NONE
National MS Society grant funding to support neuroimmunology fellowship
NONE
NONE
NONE
NONE
NONE
NONE
- Christophe Demattei, PhD,
None
NONE
None
NONE
NONE
NONE
NONE
I have served as a consultant for EMD Serono, Genentech and Novartis
NONE
NONE
NONE
NONE
NONE
NONE
National MS Society grant funding to support neuroimmunology fellowship
NONE
NONE
NONE
NONE
NONE
NONE
- Ugur Uygunoglu, MD,
None
NONE
None
NONE
NONE
NONE
NONE
I have served as a consultant for EMD Serono, Genentech and Novartis
NONE
NONE
NONE
NONE
NONE
NONE
National MS Society grant funding to support neuroimmunology fellowship
NONE
NONE
NONE
NONE
NONE
NONE
- Giovanni Castelnovo, MD,
None
NONE
None
NONE
NONE
NONE
NONE
I have served as a consultant for EMD Serono, Genentech and Novartis
NONE
NONE
NONE
NONE
NONE
NONE
National MS Society grant funding to support neuroimmunology fellowship
NONE
NONE
NONE
NONE
NONE
NONE
- Mikael Cohen, MD, PhD,
None
NONE
None
NONE
NONE
NONE
NONE
I have served as a consultant for EMD Serono, Genentech and Novartis
NONE
NONE
NONE
NONE
NONE
NONE
National MS Society grant funding to support neuroimmunology fellowship
NONE
NONE
NONE
NONE
NONE
NONE
- Darin T. Okuda, MD, PhD,
None
NONE
None
NONE
NONE
NONE
NONE
I have served as a consultant for EMD Serono, Genentech and Novartis
NONE
NONE
NONE
NONE
NONE
NONE
National MS Society grant funding to support neuroimmunology fellowship
NONE
NONE
NONE
NONE
NONE
NONE
- Orhun H. Kantarci, MD, PhD,
None
NONE
None
NONE
NONE
NONE
NONE
I have served as a consultant for EMD Serono, Genentech and Novartis
NONE
NONE
NONE
NONE
NONE
NONE
National MS Society grant funding to support neuroimmunology fellowship
NONE
NONE
NONE
NONE
NONE
NONE
- Daniel Pelletier, MD,
None
NONE
None
NONE
NONE
NONE
NONE
I have served as a consultant for EMD Serono, Genentech and Novartis
NONE
NONE
NONE
NONE
NONE
NONE
National MS Society grant funding to support neuroimmunology fellowship
NONE
NONE
NONE
NONE
NONE
NONE
- Christina Azevedo, MD, PhD,
None
NONE
None
NONE
NONE
NONE
NONE
I have served as a consultant for EMD Serono, Genentech and Novartis
NONE
NONE
NONE
NONE
NONE
NONE
National MS Society grant funding to support neuroimmunology fellowship
NONE
NONE
NONE
NONE
NONE
NONE
- Philippe Marin, PhD,
None
NONE
None
NONE
NONE
NONE
NONE
I have served as a consultant for EMD Serono, Genentech and Novartis
NONE
NONE
NONE
NONE
NONE
NONE
National MS Society grant funding to support neuroimmunology fellowship
NONE
NONE
NONE
NONE
NONE
NONE
- Sylvain Lehmann, MD, PhD,
None
NONE
None
NONE
NONE
NONE
NONE
I have served as a consultant for EMD Serono, Genentech and Novartis
NONE
NONE
NONE
NONE
NONE
NONE
National MS Society grant funding to support neuroimmunology fellowship
NONE
NONE
NONE
NONE
NONE
NONE
- Aksel Siva, MD, PhD,
None
NONE
None
NONE
NONE
NONE
NONE
I have served as a consultant for EMD Serono, Genentech and Novartis
NONE
NONE
NONE
NONE
NONE
NONE
National MS Society grant funding to support neuroimmunology fellowship
NONE
NONE
NONE
NONE
NONE
NONE
- Thibault Mura, MD, PhD and
None
NONE
None
NONE
NONE
NONE
NONE
I have served as a consultant for EMD Serono, Genentech and Novartis
NONE
NONE
NONE
NONE
NONE
NONE
National MS Society grant funding to support neuroimmunology fellowship
NONE
NONE
NONE
NONE
NONE
NONE
- Christine Lebrun-Frenay, MD, PhD
None
NONE
None
NONE
NONE
NONE
NONE
I have served as a consultant for EMD Serono, Genentech and Novartis
NONE
NONE
NONE
NONE
NONE
NONE
National MS Society grant funding to support neuroimmunology fellowship
NONE
NONE
NONE
NONE
NONE
NONE
- From the Department of Neurology (M.R., E.T., G.C.), Nîmes University Hospital Center, Univ. Montpellier; Functional Genomics Institute (M.R., E.T., L.D.T.T., P.M.), Univ. Montpellier, CNRS, INSERM; Department of Biostatistics (S.L.-C., C.D., T.M.), Clinical Epidemiology, Public Health and Innovation in Methdology (BESPIM), Nîmes University Hospital Center, Univ. Montpellier, France; Department of Neurology (U.U., A.S.), Cerrahpasa School of Medecine, University of Istanbul, Turkey; Centre de Ressources et Compétences Sclérose En Plaques (CRCSEP) (M.C., C.L.-F.), CHU de Nice, Hôpital Pasteur 2, Université Côte d’Azur, UR2CA-URRIS, France; UT Southwestern Medical Center (D.T.O.), Dallas, TX; Mayo Clinic (O.H.K.), Rochester, MN; University of South California (D.P., C.A.), Los Angeles; and LBPC-PPC (S.L.), Univ. Montpellier, CHU Montpellier, INM, INSERM, France.
- Correspondence
Prof. Thouvenot eric.thouvenot{at}chu-nimes.fr
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Nicole Sur and Dr. Mausaminben Hathidara
► Watch
Related Articles
- No related articles found.